News Sourcing Guide

【Crystal Lake】Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology to Enhance Skincare Dosing Precision

Jul 21, 2026

Editor’s Note

**Editor’s Note:** Aptar Beauty’s launch of the NeoDropper Autoload marks a significant advancement in precision dosing for premium skincare, debuting with Dermalogica’s FutureCode Booster. This innovation underscores the industry’s shift toward smarter, user-friendly packaging solutions.

Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology

AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing, and protection technologies, as well as consumer product dispensing, has announced the first launch of its innovative auto-loading, metered dropper technology, named NeoDropper Autoload. Aptar’s technology is applied to Dermalogica’s FutureCode Booster skincare product. This next-generation dropper packaging is specifically designed for premium skincare and medical aesthetics brands, aiming to support precise dispensing and enhance user experience, meeting consumer demands for dose control, convenience, and hygienic use.
Aptar’s NeoDropper Autoload combines a twist-and-press dispensing mechanism with an auto-loading dropper cap that automatically fills the applicator with a consistent dose after each use, revolutionizing the dropper experience. The unique short applicator design is intended to prevent breakage while improving hygiene and dose control. The straw inside the bottle allows consumers to use the last drop of the formula, helping to reduce product waste.

“We are driving innovation in dropper and metered packaging to respond to evolving market demands and shape the future of precision dispensing for forward-thinking skincare brands.” – Xavier Joseph, Vice President of Global Marketing and Innovation at Aptar Beauty

As consumers seek clinically validated products, medical skincare brands continue to gain popularity in the U.S. beauty market. Consequently, beauty brands are increasingly turning to advanced dispensing technologies to preserve formulations containing potent ingredients and active substances that require protection and precise dosing.
NeoDropper Autoload is designed to address this market shift through next-generation dropper technology that enhances formula integrity, hygiene, and dispensing precision to reduce product waste.
Professional-grade skincare brand Dermalogica has selected NeoDropper Autoload for its new FutureCode Booster serum, an advanced anti-aging treatment designed to reverse daily DNA-related damage and combat visible skin aging.

“FutureCode Booster has been well-received by consumers, especially in terms of dispensing performance, ease of use, and overall user experience. Feedback highlights the value of delivering a consistent dose in a controlled and hygienic manner, demonstrating how thoughtful packaging design can enhance product performance and daily usability.” – Manuela DeForge, Packaging Engineering Manager at Dermalogica

This launch marks the latest milestone in the long-term collaboration between Dermalogica and Aptar, reflecting their shared ambition to enhance product performance and consumer experience through packaging innovation. In 2022, Dermalogica became the first premium skincare brand to adopt Aptar’s Future, a fully recyclable mono-material polyethylene dispensing pump (when used with PE or PET bottles), thereby improving the circularity of its cleansing product line.

Aptar is a global leader in drug delivery, dosing, and protection technologies, as well as consumer product dispensing. Aptar partners with the world’s leading healthcare and consumer brands to deliver drugs and create exceptional user experiences. Serving multiple markets including pharmaceuticals, beauty, food, and beverage, Aptar combines market expertise with proprietary design, engineering, and science to develop innovative solutions that help improve lives worldwide. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 people in 20 countries. For more information, visit http://www.aptar.com.

AV Laboratories Launches Fertility Clinic Skincare Program at ESHRE 2026 in London

AV Laboratories, a research-driven skincare company founded by pioneers in IVF solutions, regenerative medicine, and stem cell therapy, today announced its participation in the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2026), held July 5-8, 2026, in London. The company will welcome clinicians, embryologists, fertility specialists, researchers, partners, and industry participants at Booth A22.

“ESHRE is deeply meaningful to us because it is the community that shaped our scientific foundation. Our work in IVF has given us a profound understanding of the importance of cellular health, precision, and care. Through AV Laboratories, we bring the same philosophy into skincare, helping women feel supported during some of the most important and sensitive stages of their lives.” – Ami Mezezi, CEO and Co-Founder of AV Laboratories

At ESHRE 2026, AV Laboratories will showcase its award-winning skincare product portfolio and a new vision for women’s skincare. This vision links reproductive science, cellular health, and skin longevity through a more comprehensive understanding of how skin needs change throughout life. By returning to the IVF community, AV Laboratories aims to start a new conversation about how fertility and women’s health providers can support not only clinical outcomes but also the daily confidence and well-being of the women they serve.

“We can no longer compartmentalize these experiences; women’s health and skincare should be seen as an interconnected journey. As a mother of two, I remember the importance of feeling confident in the products I used, especially while breastfeeding. During that life stage, you carefully consider everything—your diet, your supplies, and what touches your skin. We want to make at least one part of that journey simpler by creating skincare that women can truly trust.” – Jessica Martin, Director of Corporate Communications at AV Laboratories

“AV Laboratories does not formulate products in isolation. I spend a great deal of time thinking about how to build the company around real clinical needs rather than assumptions. The dual-action formulas are designed for simple, effective daily care, combining AVL SOM3® with clinical-grade active ingredients that work synergistically with the skin to support hydration, barrier resilience, visible firmness, elasticity, radiance, and a smoother, healthier skin appearance.” – Sylwia Pawlaczyk, COO and Chief Formulator at AV Laboratories

“As a dermatologist and a mother of two children through IVF, I know firsthand how thoughtful women become about every choice during this journey. Patients are making deeply personal decisions about what they put in and on their bodies, and they deserve skincare that is clear, thoughtful, and grounded in real science. What excites me about AV Laboratories is that it combines breakthrough science, sophisticated formulations, and a genuine understanding of women’s needs—from IVF and motherhood to long-term skin longevity.” – Dr. Dendy Engelman, Board-Certified Dermatologist and Scientific Advisory Board Member at AV Laboratories

At Booth A22, AV Laboratories will offer an educational experience designed around the brand’s journey from IVF science to molecular skincare, including:

AV Laboratories由體外受精解決方案先驅創立，將於倫敦ESHRE 2026年會推出生育診所計劃，展示其屢獲殊榮的護膚品。 AP圖片

AV Laboratories Fertility Clinic Skincare Program
For fertility clinics, AV Laboratories’ clinical program is designed to be easy to introduce and convenient for patient communication. The program provides clinics with a way to offer science-backed skincare education, trustworthy product recommendations, and supportive health resources to women who may be more conscious of the products they use during fertility treatment, pregnancy, breastfeeding, and beyond.

“Through my work with fertility clinics, I see the level of trust patients place in their care teams. Women undergoing fertility treatment want guidance they can deeply trust in every aspect of their care, including the products they can use on their skin. A thoughtful, science-backed skincare program offers clinics a simple way to meet this need and enhance the patient experience.” – Nathalie Boonen, IVF and Medical Clinic Partnership Specialist

AV Laboratories invites ESHRE 2026 attendees to visit Booth A22 to experience the brand’s skincare product portfolio, learn more about AVL SOM3®, and explore collaboration opportunities in fertility, women’s health, and clinical wellness.
To schedule a meeting with AV Laboratories during ESHRE 2026, attendees should contact the team in advance or visit Booth A22 during exhibition hours.
From Pioneering IVF Solutions to Reimagining the Appearance of Skin Aging
Before founding AV Laboratories, Ami Mezezi and Monica Mezezi helped shape the IVF industry through their work at LifeGlobal. LifeGlobal, founded by Monica, pioneered single-step IVF culture media, a breakthrough that helped transform care standards in fertility clinics worldwide. LifeGlobal was acquired by CooperSurgical in 2018. Ami also co-founded EvolveGene, a genetic testing company focused on using molecular insights to support smarter, personalized health decisions, which was also acquired by CooperSurgical. In 2021, they founded CaseBioscience, a company developing technologies for regenerative medicine and stem cell therapy. At AV Laboratories, Ami and Monica leverage their deep experience in reproductive health, regenerative medicine, quality-controlled manufacturing, and cell science to reimagine how we approach the appearance of skin aging.
About AV Laboratories
AV Laboratories is a research-driven skincare company founded by pioneers in IVF solutions, biotechnology, molecular biology, stem cell research, and cell science. The company develops advanced skincare solutions rooted in its patented AVL SOM3® technology, a molecular skincare complex inspired by decades of work in cellular nourishment, precision formulation, and women’s health. AV Laboratories is committed to helping skin look and feel healthier, longer through science-backed, clinically validated, and responsibly formulated skincare.

Full article: View original |
⏰ Published on: July 21, 2026